Summary:
This is a 24 week study to asses the efficacy & safety in subjects with moderate to very severe COPD, compared with a placebo and Spiriva Handihaler.
Qualified Participants Must:
• Be between 40 and 80 years of age
•
If Female must be of non child bearing potential, those of child bearing potential will have a negative serum pregnancy test
•
Have a clinical history of COPD
•
Be a current of former smoker with a history of at least 10 pack-years
Qualified Participants May Receive:
Study medication, study related medical care and may be compensated for time and travel